Gamida Cell Appoints Abigail Jenkins To Succeed Julian Adams As President And CEO

RTTNews | 1119 days ago
Gamida Cell Appoints Abigail Jenkins To Succeed Julian Adams As President And CEO

(RTTNews) - Gamida Cell Ltd. (GMDA) announced Monday that Abigail "Abbey" Jenkins, has joined as President & CEO. Jenkins has also been appointed to Gamida Cell's Board of Directors. Jenkins succeeds Julian Adams, who is retiring in accordance with planned succession and will continue to serve on the company's Board of Directors.

Jenkins brings over 20 years of leadership experience in the biopharmaceutical industry delivering life-enhancing therapies from research to commercialization for patients in need.

Most recently, she served as the Chief Commercial and Business Officer at Lyndra Therapeutics. Prior to Lyndra, she served as Senior Vice President and Business Unit Head of Vaccines at Emergent BioSolutions.

Jenkins also served as Chief Commercial Officer and U.S. Business Head at Aquinox Pharmaceuticals. Additionally, she has held senior commercial and business development positions at Relypsa, Actavis, Pfizer and Medimmune/AZ.

read more
FDA Approves Omisirge Cell Therapy For Blood Cancers

FDA Approves Omisirge Cell Therapy For Blood Cancers

The U.S. Food and Drug Administration approved Gamida Cell Ltd.'s Omisirge (omidubicel-onlv) cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation. Gamida Cell shares gained around 39 percent on Monday's regular trading. The gain continued in the after hours trading with a further growth of 4 percent.
RTTNews | 909 days ago
Sensex, Nifty Open Lower On Weak Global Cues

Sensex, Nifty Open Lower On Weak Global Cues

Indian shares were moving lower on Monday, tracking weak cues from global markets as signs of escalation of the trade war between U.S. and China sapped investors' appetite for riskier assets.
RTTNews | 26 minutes ago
Australian Market Maintains Early Losses In Mid-market

Australian Market Maintains Early Losses In Mid-market

The Australian stock market is maintaining its early losses in mid-market trading on Monday, adding to the slight losses in the previous session, following the broadly negative cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is falling to the 8,900.00 level, with weakness across most sectors led by energy and technology stocks. Gold was the only bright spot.
RTTNews | 1h 18min ago
Asian Markets A Sea Of Red

Asian Markets A Sea Of Red

Asian stock markets are a sea of red on Monday, following the broadly negative cues from Wall Street on Friday, amid renewed U.S.-China trade war after US President Donald Trump threatened to massively increase tariffs on China in retaliation for China's expansive export curbs on its rare earth minerals, which are essential for manufacturing and technology.
RTTNews | 1h 53min ago
Indonesia Shares Likely To Open Under Water On Monday

Indonesia Shares Likely To Open Under Water On Monday

The Indonesia stock market has moved higher in two straight sessions, collecting more than 90 points or 1.1 percent along the way. Now at a fresh record closing high, the Jakarta Composite Index sits just beneath the 8,260-point plateau although it's overdue for profit taking on Monday.
RTTNews | 3h 24min ago
Hong Kong Shares Tipped To Open Under Pressure On Monday

Hong Kong Shares Tipped To Open Under Pressure On Monday

The Hong Kong stock market had moved lower in five straight sessions, shedding almost 1,000 points or 3.6 percent along the way. The Hang Seng Index now sits just above the 26,290-point plateau and it may extend its slide on Monday.
RTTNews | 3h 39min ago
China Stock Market May Take Further Damage On Monday

China Stock Market May Take Further Damage On Monday

The China stock market on Friday snapped the three-day winning streak in which it had climbed more than 100 points or 2.6 percent. The Shanghai Composite Index now rests just beneath the 3,900-point plateau and it's tipped to open in the red again on Monday.
RTTNews | 3h 54min ago